Left Menu
Development News Edition

EU seals second COVID-19 vaccine deal as WHO scheme deadline looms

The European Union has agreed to buy a potential COVID-19 vaccine from Sanofi and GSK in its second such deal to secure supplies, as a deadline for joining the World Health Organization's (WHO) vaccine purchase programme looms.

Reuters | Geneva | Updated: 18-09-2020 18:06 IST | Created: 18-09-2020 17:03 IST
EU seals second COVID-19 vaccine deal as WHO scheme deadline looms
Representative Image. Image Credit: ANI

The European Union has agreed to buy a potential COVID-19 vaccine from Sanofi and GSK in its second such deal to secure supplies, as a deadline for joining the World Health Organization's (WHO) vaccine purchase programme looms. The deal will see the French and British drugmakers, which have teamed up to manufacture a recombinant protein-based vaccine they hope to get approved next year, provide the EU with up to 300 million doses.

Friday's agreement confirms an announcement made on July 31 by the two companies and follows an earlier deal between the EU and AstraZeneca for up to 400 million shots. In return for the right to the doses, the European Commission will finance part of the upfront costs faced by vaccine producers. The vaccine doses themselves will be bought by EU countries.

The latest deal comes on deadline day for members of the WHO to join its COVAX scheme, which aims to buy COVID-19 vaccines and ensure immunisations are fairly and efficiently distributed. So far, 92 lower-income nations are seeking assistance via COVAX, part of the WHO's ACT Accelerator to boost development of vaccines, therapeutics and diagnostics to combat the pandemic.

Some 80 higher-income nations have expressed interest, but many have yet to join as they scramble to secure supplies separately. France will provide funding for the initiative but will not source shots through it, a health ministry official said on Thursday, after Paris decided to be part of a joint scheme arranged through the EU.

There is currently no internationally-approved vaccine for COVID-19, the illness caused by the new coronavirus, which has claimed more than 946,000 lives and derailed the world economy. For Sanofi and GSK, the deal follows a $2.1 billion agreement with the United States in July for 100 million doses, with an option for Washington to purchase an additional 500 million, as well as a UK deal for 60 million doses.

Sanofi and GSK started clinical trials of their vaccine this month and aim to reach the final testing stage by December. The vaccine candidate uses the same recombinant protein-based technology as one of Sanofi's seasonal influenza vaccines. It will be coupled with an adjuvant, a substance that acts as a booster to the vaccine, made by GSK.

The two companies are scaling up manufacturing to be ready to produce up to one billion doses per year. Sanofi is also working on another potential COVID-19 vaccine with U.S. company Translate Bio, using a technology called mRNA. FACTBOX- The race for a coronavirus vaccine FACTBOX-U.S., UK spend billions to take lead in securing coronavirus vaccines


TRENDING

OPINION / BLOG / INTERVIEW

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Guinea’s elections hearken back to the autocracy and violence of its past

... ...

Videos

Latest News

Liberty Steel begins operations in India; starts production at Adhunik plant in Odisha

Liberty Steel Group has begun its operations in India with production starting at Adhunik Metaliks and Zion Steel, which Liberty had acquired earlier this year. UK-based Liberty Steel Group is part of diversified GFG Alliance, owned by Indi...

Over Rs 113 cr transferred in 3.4 lakhs farmers' account in 19 flood-affected districts of UP

Uttar Pradesh Chief Minister Yogi Adityanath has deposited Rs 113.21 crore in the account of 3,48,511 farmers of 19 flood-affected districts of the state. He made an online payment to the farmers to compensate them for their crops destroyed...

Meghalaya CM launches 'micro ATM' service in rural areas

Meghalaya Chief Minister Conrad K Sangma has launched the micro ATM service in rural areas of the state. He distributed the handheld devices, through which money could be withdrawn, to banking correspondent agents BCA on Wednesday.Micro ATM...

PREVIEW-Soccer-Dortmund eye Ruhr derby win to bounce back from European flop

Borussia Dortmund face their first major obstacle in the Bundesliga when they host bitter Ruhr valley rivals Schalke 04 on Saturday and any slip-up following their mid-week European loss will instantly pile more pressure on Lucien Favres te...

Give Feedback